DLB
$68.16
Dolby Laboratories
($.21)
(.31%)
Earnings Details
3rd Quarter June 2022
Tuesday, August 9, 2022 4:15:00 PM
Tweet Share Watch
Summary

Dolby Labs Sees Fourth Quarter Below Estimates

Dolby Laboratories (DLB) reported 3rd Quarter June 2022 earnings of $0.42 per share on revenue of $289.6 million. The consensus earnings estimate was $0.37 per share on revenue of $294.0 million. Revenue grew 1.0% on a year-over-year basis.

The company said it expects fourth quarter non-GAAP earnings of $0.68 to $0.83 per share on revenue of $295.0 million to $325.0 million. The current consensus earnings estimate is $0.87 per share on revenue of $326.80 million for the quarter ending September 30, 2022.

Dolby Laboratories Inc develops audio, video and voice technologies that transform entertainment and communications in mobile devices, at the cinema, at home and at work.

Results
Reported Earnings
$0.42
Earnings Whisper
-
Consensus Estimate
$0.37
Reported Revenue
$289.6 Mil
Revenue Estimate
$294.0 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Dolby Laboratories Reports Third Quarter Fiscal 2022 Financial Results

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2022. For the third quarter, Dolby reported total revenue of $289.6 million, compared to $286.8 million for the third quarter of fiscal 2021.

"While the macroeconomic environment remains uncertain, we are focused on executing on our growth initiatives and remain confident in our long-term opportunity," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We continue to grow the adoption of Dolby Vision and Dolby Atmos across a broadening set of use cases, highlighted this quarter by important wins in mobile with Dolby Vision capture, and in music and automotive with Dolby Atmos."

Third quarter GAAP net income was $39.6 million, or $0.39 per diluted share, compared to GAAP net income of $54.6 million, or $0.52 per diluted share, for the third quarter of fiscal 2021. On a non-GAAP basis, third quarter net income was $68.7 million, or $0.68 per diluted share, compared to $74.8 million, or $0.71 per diluted share, for the third quarter of fiscal 2021. Third quarter cash flows from operations were $172.6 million, compared to $172.4 million for the third quarter of fiscal 2021. A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release. 

Recent Business Highlights

  • Xiaomi announced their new 12S smartphone series - the first Android phone capable of recording video in Dolby Vision.
  • Dolby Atmos Music is now available on Tencent Music’s QQ Music in China and Melon in South Korea.
  • Li Auto announced their first vehicle supporting Dolby Atmos.
  • The UEFA Champions League Final was broadcast live in Dolby Atmos and Dolby Vision on Canal+.

Impact of Recent Events

Dolby’s financial results for the third quarter of fiscal 2022 rely on estimates of royalty-based revenue that take into consideration the macroeconomic effect of certain events, including COVID-19, supply chain constraints, and consumer demand for electronic products. In addition, our actual results could differ materially from the estimates we are providing below due in part to the increased uncertainty resulting from these items as well as the geopolitical instability in Europe and continuing concerns around inflation. The uncertainty resulting from these factors has greatly reduced our visibility into our future outlook. To the extent possible, the estimates we are providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that we face, and the section captioned "Risk Factors" in our Quarterly Report on Form 10-Q for the third quarter of fiscal 2022, filed on or around the date hereof.

Dividend

Today, Dolby announced a cash dividend of $0.25 per share of Class A and Class B common stock, payable on August 31, 2022, to stockholders of record as of the close of business on August 23, 2022.

Stock Repurchase Program

Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of its Class A Common Stock to approximately $581 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that the company considers appropriate.

Financial Outlook - Full Year of Fiscal 2022 and Fourth Quarter of Fiscal 2022

We have lowered our outlook to reflect the impact of the macroeconomic environment, primarily on our estimates for the mobile, broadcast, and PC markets.

Full Year Fiscal 2022

Dolby is providing the following estimates for its full year fiscal 2022:

  • Total revenue is estimated to range from $1.27 billion to $1.30 billion.
  • Gross margin percentages are anticipated to range from 88.5% to 89.5% on a GAAP basis and from 89% to 90% on a non-GAAP basis.
  • Operating expenses are anticipated to range from $901 million to $911 million on a GAAP basis and from $740 million to $750 million on a non-GAAP basis.
  • Operating margin percentages are anticipated to range from 17% to 19% on a GAAP basis and from 30% to 32% on a non-GAAP basis.
  • Effective tax rate is anticipated to range from 16% to 17% on a GAAP basis and 17% to 18% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $1.91 to $2.06 on a GAAP basis and from $3.22 to $3.37 on a non-GAAP basis.

Fourth Quarter of Fiscal 2022

Dolby is also providing the following estimates for its fourth quarter of fiscal 2022:

  • Total revenue is estimated to range from $295 million to $325 million.
  • Operating expenses are anticipated to range from $210 million to $220 million on a GAAP basis and from $180 million to $190 million on a non-GAAP basis.
  • Effective tax rate is anticipated to range from 21% to 22% on a GAAP basis and 18% to 19% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $0.40 to $0.55 on a GAAP basis and from $0.68 to $0.83 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss third quarter fiscal 2022 financial results for Dolby Laboratories at 1:30 p.m. PT (4:30 p.m. ET) on Tuesday, August 9, 2022. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-844-200-6205 (or dialing 1-929-526-1599 for international callers) and entering confirmation code 330163.

A replay of the call will be available from 4:30 p.m. PT (7:30 p.m. ET) on Tuesday, August 9, 2022, until 10:30 p.m. PT on Tuesday, August 16, 2022 (1:30 a.m. ET on Wednesday, August 17, 2022), by dialing 1-866-813-9403 (international callers can access the replay by dialing +44-204-525-0658) and entering the confirmation code 175460. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.

Amortization of acquisition-related intangibles: We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating performance.

Restructuring charges: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Income tax adjustments: We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.

Other operating income adjustments: In the second quarter of fiscal 2022, we recorded an expense of $34.4 million related to a one-time settlement and accrual in connection with indemnification requests under commercial agreements that we assumed in an acquisition in 2014 related to our Cinema products business. We expect this settlement and related accrual to fully resolve this matter. Also, in the first quarter of fiscal 2021, we recorded a one-time gain on the sale of property, which was previously classified as held for sale. The property was 51% owned by the controlling interest, therefore 51% of the gain recognized has been attributed to the controlling interest. We have excluded both of these items as they are unusual, non-recurring events that are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for the fourth quarter of fiscal 2022 and full year fiscal 2022, our ability to advance our long-term objectives, our stock repurchase program, and future dividend payments are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of COVID-19 on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; consumer demand for products that incorporate Dolby technologies; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; the impact to the overall cinema market, including closures or limitations of cinema capacity and resulting adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; temporary Dolby office closures and other actions to protect Dolby’s workforce; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues, such as the conflict between Russia and Ukraine; risks associated with trends in the markets in which Dolby operates, including the Broadcast, Mobile, Consumer Electronics, PC, Cinema, Developer Platform Services, and Other Markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks that the continued shift in content distribution from optical disc-based and other traditional media to online and streaming media content could result in fewer devices with Dolby technologies or less revenue from such devices; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in our most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. We partner with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories, Inc. in the United States and/or other countries. Other trademarks remain the property of their respective owners.

DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts; unaudited)

 Fiscal Quarter Ended Fiscal Year-To-Date Ended
 July 1,
2022
June 25,
2021
 July 1,
2022
June 25,
2021
Revenue:     
Licensing$                269,289 $                271,569  $                915,406 $                948,159 
Products and services                     20,296                      15,230                       60,183                      48,072 
Total revenue                   289,585                    286,799                     975,589                    996,231 
      
Cost of revenue:     
Cost of licensing                     13,756                      12,480                       45,363                      41,486 
Cost of products and services                     22,201                      19,164                       58,818                      57,840 
Total cost of revenue                     35,957                      31,644                     104,181                      99,326 
      
Gross margin                   253,628                    255,155                     871,408                    896,905 
      
Operating expenses:     
Research and development                     62,859                      62,094                     199,104                    191,674 
Sales and marketing                     87,114                      80,714                     268,514                    234,205 
General and administrative                     57,113                      56,116                     218,250                    169,968 
Gain on sale of assets                            —                             —                              —                     (13,871)
Restructuring charges                          976                           140                         6,043                      10,904 
Total operating expenses                   208,062                    199,064                     691,911                    592,880 
      
Operating income                     45,566                      56,091                     179,497                    304,025 
      
Other income/(expense):     
Interest income                       1,416                           741                         3,230                        2,677 
Interest expense                           (84)                         (108)                          (255)                         (360)
Other income, net                       2,514                        2,401                         1,833                        5,112 
Total other income                       3,846                        3,034                         4,808                        7,429 
      
Income before income taxes                     49,412                      59,125                     184,305                    311,454 
Provision for income taxes                      (9,802)                      (4,565)                     (28,166)                    (37,859)
Net income including controlling interest                     39,610                      54,560                     156,139                    273,595 
Less: net (income)/loss attributable to controlling interest                           (13)                            61                            192                       (7,559)
Net income attributable to Dolby Laboratories, Inc.$                  39,597  $                  54,621   $                156,331  $                266,036  
      
Net income per share:     
Basic$                      0.40 $                      0.54  $                      1.55 $                      2.63 
Diluted$                      0.39 $                      0.52  $                      1.52 $                      2.54 
Weighted-average shares outstanding:     
Basic                   100,213                    101,351                     100,936                    101,177 
Diluted                   101,474                    104,633                     102,993                    104,607 
              

DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands; unaudited)

 July 1,
2022
September 24,
2021
ASSETS  
Current assets:  
Cash and cash equivalents$                858,905 $             1,225,380 
Restricted cash                       8,352                        7,652 
Short-term investments                   156,812                      38,839 
Accounts receivable, net                   236,229                    232,609 
Contract assets, net                   170,402                    182,316 
Inventories, net                     24,096                      10,965 
Prepaid expenses and other current assets                     49,923                      62,737 
Total current assets                1,504,719                 1,760,498 
Long-term investments                   106,726                      62,819 
Property, plant and equipment, net                   517,870                    534,381 
Operating lease right-of-use assets                     53,702                      67,128 
Goodwill and intangible assets, net                   487,533                    463,584 
Deferred taxes                   183,545                    156,020 
Other non-current assets                     65,841                      61,257 
Total assets$             2,919,936  $             3,105,687  
   
LIABILITIES AND STOCKHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable$                  16,821 $                  17,779 
Accrued liabilities                   229,267                    262,728 
Income taxes payable                       3,850                        1,334 
Contract liabilities                     21,216                      18,473 
Operating lease liabilities                     14,331                      15,403 
Total current liabilities                   285,485                    315,717 
Non-current contract liabilities                     24,350                      23,713 
Non-current operating lease liabilities                     44,257                      56,715 
Other non-current liabilities                   106,319                    105,310 
Total liabilities                   460,411                    501,455 
   
Stockholders’ equity:  
Class A common stock                            57                             59 
Class B common stock                            41                             41 
Retained earnings                2,484,689                 2,607,909 
Accumulated other comprehensive loss                    (30,426)                    (10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.                2,454,361                 2,597,979 
Controlling interest                       5,164                        6,253 
Total stockholders’ equity                2,459,525                 2,604,232 
Total liabilities and stockholders’ equity$             2,919,936  $             3,105,687  

DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands; unaudited)

 Fiscal Year-To-Date Ended
 July 1,
2022
June 25,
2021
Operating activities:  
Net income including controlling interest$                156,139 $                273,595 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization                     69,382                      70,701 
Stock-based compensation                     87,963                      75,562 
Amortization of operating lease right-of-use assets                     11,658                      12,744 
Amortization of premium on investments                       1,109                        1,051 
Provision for/(benefit from) credit losses                       2,166                          (567)
Deferred income taxes                    (29,143)                    (26,479)
Gain on sale of assets                            —                     (13,871)
Other non-cash items affecting net income                      (2,388)                      (3,293)
Changes in operating assets and liabilities:  
Accounts receivable, net                      (5,395)                    (93,848)
Contract assets, net                     11,999                       (5,402)
Inventories                    (12,231)                     14,828 
Operating lease right-of-use assets                         (941)                      (4,982)
Prepaid expenses and other assets                      (1,169)                     15,468 
Accounts payable and accrued liabilities                    (29,782)                     31,788 
Income taxes, net                     17,023                        4,293 
Contract liabilities                       3,314                           512 
Operating lease liabilities                    (10,539)                      (7,507)
Other non-current liabilities                      (1,898)                      (6,613)
Net cash provided by operating activities                   267,267                    337,980 
   
Investing activities:  
Purchases of marketable securities                  (248,156)                    (48,066)
Proceeds from sales of marketable securities                       8,970                        7,332 
Proceeds from maturities of marketable securities                     75,890                      37,040 
Purchases of property, plant, and equipment                    (37,218)                    (42,619)
Proceeds from sale of assets                            —                      16,365 
Payments for business combinations, net of cash acquired                    (38,171)                            — 
Purchases of intangible assets                    (11,528)                            — 
Purchases of other investments                      (5,000)                            — 
Net cash used in investing activities                  (255,213)                    (29,948)
   
Financing activities:  
Proceeds from issuance of common stock                     53,600                      89,148 
Repurchase of common stock                  (310,486)                  (149,764)
Payment of cash dividend                    (75,816)                    (66,883)
Distribution to controlling interest                      (1,435)                      (7,362)
Shares repurchased for tax withholdings on vesting of restricted stock                    (33,994)                    (30,789)
Net cash used in financing activities                  (368,131)                  (165,650)
   
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash                      (9,698)                       4,891 
Net increase/(decrease) in cash, cash equivalents, and restricted cash                  (365,775)                   147,273 
Cash, cash equivalents, and restricted cash at beginning of period                1,233,032                 1,079,979 
Cash, cash equivalents, and restricted cash at end of period$                867,257  $             1,227,252  


GAAP to Non-GAAP Reconciliations
(in millions, except per share data; unaudited)
      
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the third quarter and year-to-date period ended July 1, 2022 and June 25, 2021:
      
Net income:Fiscal Quarter Ended Fiscal Year-To-Date Ended
 July 1,
2022
June 25,
2021
 July 1,
2022
June 25,
2021
GAAP net income$                     39.6 $                     54.6  $                   156.3 $                266.0 
Stock-based compensation (1)                        27.6                         24.9                          88.0                      75.6 
Amortization of acquisition-related intangibles (2)                          1.8                           2.5                            7.3                        7.5 
Other operating income adjustments                            —                             —                          34.4                       (6.8)
Restructuring charges                          1.0                           0.1                            6.0                      10.9 
Income tax adjustments                         (1.3)                         (7.3)                        (24.9)                    (30.3)
Non-GAAP net income$                     68.7 $                     74.8  $                   267.1 $                322.9 
      
(1) Stock-based compensation included in above line items:     
Cost of products and services$                       0.4 $                       0.5  $                       1.4 $                    1.6 
Research and development 9.2                           7.3   28.4                      22.4 
Sales and marketing 9.7                           9.3   31.8                      28.2 
General and administrative 8.3                           7.8   26.4                      23.4 
      
(2) Amortization of acquisition-related intangibles included in above line items:     
Cost of licensing$                       0.1 $                       0.7  $                       1.4 $                    2.1 
Cost of products and services                          0.8                           0.9                            2.3                        2.7 
Research and development                          0.1                           0.1                            0.3                        0.3 
Sales and marketing                          0.8                           0.8                            3.0                        2.4 
General and administrative                            —                             —                            0.3                          — 
      
Diluted earnings per share:Fiscal Quarter Ended Fiscal Year-To-Date Ended
 July 1,
2022
June 25,
2021
 July 1,
2022
June 25,
2021
GAAP diluted earnings per share$                     0.39 $                     0.52  $                     1.52 $                  2.54 
Stock-based compensation                        0.27                         0.24                          0.85                      0.73 
Amortization of acquisition-related intangibles                        0.02                         0.02                          0.08                      0.06 
Other operating income adjustments                            —                             —                          0.33                     (0.06)
Restructuring charges                        0.01                             —                          0.06                      0.11 
Income tax adjustments                       (0.01)                       (0.07)                        (0.23)                    (0.29)
Non-GAAP diluted earnings per share$                     0.68 $                     0.71  $                     2.61 $                  3.09 
      
      
Shares used in computing diluted earnings per share                         101                          105                           103                       105 
      
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the fourth quarter of fiscal 2022 and fiscal 2022 included in this release:
      
Gross margin:    Fiscal 2022
GAAP gross margin (low - high end of range)    88.5% - 89.5%
Stock-based compensation           0.2%
Amortization of acquisition-related intangibles           0.3%
Non-GAAP gross margin (low - high end of range)    89% - 90%
      
Operating expenses: Q4 2022  Fiscal 2022
GAAP operating expenses (low - high end of range) $210 - $220  $901 - $911
Stock-based compensation                           (29)                       (116)
Amortization of acquisition-related intangibles                             (1)                           (5)
Other operating income adjustments                             —                          (34)
Restructuring charges, net                             —                            (6)
Non-GAAP operating expenses (low - high end of range) $180 - $190  $740 - $750
      
Operating margin:   Fiscal 2022
GAAP operating margin (low - high end of range)    17% - 19%
Stock-based compensation        9%
Amortization of acquisition-related intangibles        1%
Other operating income adjustments        3%
Non-GAAP operating margin (low - high end of range)    30% - 32%
      
Effective tax rate: Q4 2022  Fiscal 2022
GAAP effective tax rate (low - high end of range) 21% - 22%  16% - 17%
Stock-based compensation (low - high end of range) (3%) - (1%)  1% - 2%
Amortization of acquisition-related intangibles (low - high end of range) (1%) - 0%  (1%) - 0%
Other (low - high end of range) (1%) - 0%  (1%) - 0%
Non-GAAP effective tax rate (low - high end of range) 18% - 19%  17% - 18%
      
Diluted earnings per share:Q4 2022 Fiscal 2022
 LowHigh LowHigh
GAAP diluted earnings per share$                     0.40 $                     0.55  $                     1.91 $                  2.06 
Stock-based compensation                        0.30                         0.30                          1.14                      1.14 
Amortization of acquisition-related intangibles                        0.02                         0.02                          0.09                      0.09 
Other operating income adjustments                            —                             —                          0.33                      0.33 
Restructuring charges, net                            —                             —                          0.06                      0.06 
Income tax adjustments                       (0.04)                       (0.04)                        (0.31)                    (0.31)
Non-GAAP diluted earnings per share$                     0.68 $                     0.83  $                     3.22 $                  3.37 
      
Shares used in computing diluted earnings per share                           99                            99                           103                       103 

Investor Contact:
Maggie O’Donnell
Dolby Laboratories
914-267-7390
investor@dolby.com

Media Contact:
Karen Hartquist
Dolby Laboratories, Inc.
415-505-8357
karen.hartquist@dolby.com


Primary Logo

Source: Dolby Laboratories